Par Drugs And Chemicals Limited logo

PAR

NSE
Par Drugs And Chemicals Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
89.58
0.04 (0.04%)
High VOLATILITY
As on 10 Jul 2026

Price History

Market Cap
₹110 Cr
SMALL CAP
P/E Ratio
8.4
Industry
Pharmaceuticals
52-Week Range
52W Low78.05+14.8%
52W High122.43-26.8%
Current Price
89.58
Circuit Limits (20%)
Lower Circuit71.66
Upper Circuit107.50
Reference Price
89.58

Investment Checklist

Triple Top on 1D — target ₹79.38
Double Top on 1D — target ₹80.73
Volume divergence: Bearish (price up, volume down)
Trend: Price below most MAs — downtrend
10/20 Bearish Cross detected 4 day(s) ago

Technical Analysis

Technical Analysis

Analysis from 2026-07-10

Confidence
51%

Trend

BEARISH
BEARISH

Price below most MAs — downtrend

EMA20
90.4
EMA50
90.31
EMA200
94.08

Price Action

MIXED
NEUTRAL
Higher Highs4
Higher Lows7
Lower Highs5
Lower Lows2

Support & Resistance Levels

Resistance (Above)
90.81
92.23
95.34
96.90
98.42
Support (Below)
88.60
87.00
84.00
82.85
81.00

Volume Analysis

TrendDECREASING
Change-86.10%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)

Recent MA Crossovers

10/20 Bearish Cross
4 days ago
SELL

Stop Loss Levels

Fixed Risk

1% Risk88.68
3% Risk86.89
5% Risk85.10
7% Risk (Custom)
83.31

Technical Levels

1x ATR (Volatility)85.86
2x ATR (Swing)82.14
3x ATR (Trend)78.42
Immediate Support88.60

Financials

Financial Analysis

MetricDec '24Mar '25Jun '25Sep '25
Revenue₹21.4 Cr₹21.9 Cr₹26 Cr₹28.7 Cr
Net Profit₹57,80,000₹1.7 Cr₹3.3 Cr₹4.1 Cr
EPS₹0.47₹2.70₹3.36
Operating Profit₹1.7 Cr₹3.1 Cr₹5.4 Cr₹6.5 Cr

Peer Comparison

Pharmaceuticals

Peer Comparison

Symbol
Name
Price
Change
P/E Ratio
Market Cap
Sun Pharmaceutical Industries Limited₹1,935.50-0.17%40.2
₹4.64L Cr
Divi's Laboratories Limited₹6,836.00+0.34%70.4
₹1.81L Cr
Torrent Pharmaceuticals Limited₹4,901.50+0.07%77.5
₹1.66L Cr
Cipla Limited₹1,439.40-0.13%30.1
₹1.16L Cr
Zydus Lifesciences Limited₹1,150.80-0.71%23.0
₹1.16L Cr
Lupin Limited₹2,496.30-0.28%21.4
₹1.14L Cr
Mankind Pharma Limited₹2,525.10-0.27%54.3
₹1.04L Cr
Dr. Reddy's Laboratories Limited₹1,244.30-1.99%25.6
₹1.04L Cr
Aurobindo Pharma Limited₹1,564.70-1.43%26.1
₹90.88K Cr
Laurus Labs Limited₹1,537.80+2.02%91.5
₹83.02K Cr
Par Drugs And Chemicals Limited₹89.58-0.04%8.4
₹110 Cr

Corporate Information

Large Deals

View All

Bulk, Block and Short deals reported for this stock.

Loading Deals...

Corporate Actions

Recent actions

View All
Ex DatePurposeType
23 Dec 2024
Extra Ordinary General Meeting
OTHERS
13 Sept 2024
Annual General Meeting
AGM
08 Sept 2023
Annual General Meeting
AGM
01 Sept 2022
Annual General Meeting
AGM
22 Nov 2021
Interim Dividend - Rs 1.25 Per Share
INTERIM_DIVIDEND

Announcements

Latest updates

View All
DateDescriptionLink
07 Jul 2026
Certificate under SEBI (Depositories and Participants) Regulations, 2018
25 Jun 2026
Trading Window
10 Jun 2026
Action(s) taken or orders passed
21 May 2026
Action(s) initiated or orders passed
15 May 2026
Copy of Newspaper Publication

Board Meetings

Upcoming and past meetings

View All
DatePurposeLinks
14 May 2026
Financial Results/Other business matters
14 May 2026
Board Meeting Intimation
10 Feb 2026
Board Meeting Intimation
10 Feb 2026
Financial Results/Other business matters
13 Nov 2025
Board Meeting Intimation

Corporate Events

Upcoming results & meetings

View All

No upcoming events found

We couldn't find any scheduled corporate actions for this symbol at the moment.

Shareholding Pattern

Shareholding Pattern

As of Dec 2025

Current Distribution

Trend (Last 8 Qtrs)

Latest News

News for PAR

View All
SBI Funds Management fixes price band for ₹11,692 crore IPO; Details here
positive
CNBC TV18 - Markets 2d ago

SBI Funds Management fixes price band for ₹11,692 crore IPO; Details here

At the upper end of the price band, SBI Funds Management will have a market capitalization of nearly ₹1.17 lakh crore, which puts it at par or even higher than many Nifty 50 companies.

AONETMMQ50AONETOTALLIQUIDSBIMOCAPITALPARSBILIQETFSBIMIDMOMSBINMID150SETFNIF50SETFNIFBKSETFNN50Financial ServicesHealthcare
NEWS
negative
Business Standard - Markets 10d ago

KPIT Technologies slumps as company sees Q2 FY27 revenue on par with weak Q1

KPIT Technologies slumped 13.98% to Rs 577.70 after the company said it expects Q2 FY27 revenue to remain in a similar range as Q1 FY27, indicating that the near-term weakness in demand is likely to persist.

KPITTECHPARHealthcareInformation Technology
Teja Engineering Industries IPO opens today. GMP, subscription status, other details of NSE SME IPO in 10 points
positive
LiveMint - Markets 11d ago

Teja Engineering Industries IPO opens today. GMP, subscription status, other details of NSE SME IPO in 10 points

Teja Engineering Industries IPO: According to market observers, shares of the company are available at par in the grey market today

HGINFRAMBELPARConstructionHealthcare

Frequently Asked Questions